Kamis, 07 Oktober 2021

Pfizer seeks US authorization of Covid vaccine for ages 5-11 -

The Pfizer vaccine could soon be available for children as young as five in the United States

US drugmaker Pfizer said Thursday it has formally requested emergency use authorization for its Covid-19 vaccine in children age five to 11.

Children have been infected in greater numbers in the latest coronavirus wave driven by the Delta variant, and inoculating young people is seen as key to keeping schools open and helping end the pandemic.

Pfizer tweeted early Thursday that the two companies had "officially submitted our request" to the FDA "for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to

The FDA said last week it had scheduled a meeting of an advisory committee to review the data on October 26, before giving its opinion on whether authorization should be granted.

The US Centers for Disease Control and Prevention would subsequently publish recommendations for use for healthcare providers administering the shots.

"I think we can all agree that getting a safe and effective vaccine for kids five to 11 is a really important next step in our fight against the virus."

Children in the 5-11 age group received a two-dose regimen of 10 micrograms in the trial, compared with 30 micrograms for older age groups. The shots were given 21 days apart.

Experts say children are essential to vaccinate to help achieve population immunity against the disease.

"We're working with states to set up convenient locations for parents and kids to get vaccinated, including pediatricians' offices and community sites," Zients said.

Vaccines, masks and other mitigation measures against Covid-19 have become deeply political issues in the United States -- especially for children.

About a third of parents with a child between the ages of 5 and 11 say they will vaccinate their kid as soon as possible, according to a Kaiser Family Foundation survey from the end of September.

The Pfizer vaccine received full, formal approval in the US in August and is therefore technically available to children in younger age groups if prescribed by a doctor, but US authorities have cautioned against doing this until the safety data was in.

Pfizer and BioNTech are also trialling their vaccine on infants aged six months to two years, and on children aged two to five.

The United States has an estimated 28 million children age five to 11, according to US Census Bureau data from 2019.


Adblock test (Why?)

2021-10-07 17:15:00Z

Tidak ada komentar:

Posting Komentar